Vivos Therapeutics Expands Reach with Acquisition of Sleep Center of Nevada

Deal News | Apr 16, 2025 | Globenewswire

Vivos Therapeutics, a leader in sleep apnea treatments, has signed an agreement to acquire The Sleep Center of Nevada, the largest sleep center operator in Nevada. The acquisition aims to enhance Vivos’ distribution model for its FDA-cleared sleep apnea treatment and is expected to close by Q3 2025. With an investment facilitated by New Seneca Partners, the acquisition involves a purchase price up to $9 million comprising cash and stock. This move aligns with Vivos’ strategy to provide alternative treatments to CPAP, expanding their influence in the sleep health market. The Sleep Center of Nevada, founded by Dr. Prabhu Rachakonda, is prominent in sleep disorder treatment, serving thousands monthly. Vivos plans to leverage SCN’s existing infrastructure to boost case acceptance and market penetration, with a focus on aligning their missions to make effective OSA solutions widely available. This acquisition follows Vivos’ 2024 partnership with Rebis Health, focusing on distribution strategies across certified sleep clinics.

Sectors

Healthcare
Medical Devices

Geography

United States – The acquisition and operations discussed are primarily located in the United States, specifically focusing on Nevada and Colorado.
Nevada – The Sleep Center of Nevada, the subject of the acquisition, is based in Nevada, making it a geographical focal point of the article.

Industry

Healthcare – The acquisition involves companies in the healthcare sector, focused on treating sleep disorders such as obstructive sleep apnea (OSA).
Medical Devices – Vivos Therapeutics specializes in developing FDA-cleared medical devices for treating OSA, which is central to the article.

Financials

$9 million – Total purchase price for SCN's operating assets, including cash and stock components.
$6 million – Cash portion of the purchase price to be paid by Vivos.
$1.5 million – Vivos common stock issued at closing as part of the acquisition payment.
$1.5 million – Additional stock earnout conditional on SCN meeting a financial milestone.

Participants

Name	Role	Type	Description
Vivos Therapeutics, Inc.	Acquiring Company	Company	A medical technology company focused on treatments for sleep disorders, including obstructive sleep apnea.
The Sleep Center of Nevada	Target Company	Company	The largest operator of medical sleep centers in Nevada, specializing in sleep disorder tests and treatments.
New Seneca Partners, Inc.	Investor/Advisor	Company	A private equity sponsor that assisted Vivos in the acquisition process.
Dr. Prabhu Rachakonda	Founder of SCN	Person	Board-certified specialist in internal medicine, pulmonology, and sleep medicine, founder of SCN.